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Background: Following injury to the rotator cuff and anterior cruciate ligament, a direct enthesis is not regenerated, and healing
occurs with biomechanically inferior fibrous tissue. Demineralized bone matrix (DBM) is a collagen scaffold that contains growth
factors and is a promising biological material for tendon and ligament repair because it can regenerate a direct fibrocartilaginous
insertion via endochondral ossification.
Purpose: To provide a comprehensive review of the literature investigating the use of DBM to augment tendon-bone healing in
tendon repair and anterior cruciate ligament reconstruction (ACLR).
Study Design: Systematic review.
Methods: Electronic databases (MEDLINE and EMBASE) were searched for preclinical and clinical studies that evaluated the use
of DBM in tendon repair and ACLR. Search terms included the following: (“demineralized bone matrix” OR “demineralized cortical
bone”) AND (“tissue scaffold” OR “tissue engineering” OR “ligament” OR “tendon” OR “anterior cruciate ligament” OR “rotator
cuff”). Peer-reviewed articles written in English were included, and no date restriction was applied (searches performed February
10, 2017). Methodological quality was assessed with peer-reviewed scoring criteria.
Results: The search strategy identified 339 articles. After removal of duplicates and screening according to inclusion criteria,
8 studies were included for full review (tendon repair, n ¼ 4; ACLR, n ¼ 4). No human clinical studies were identified. All 8 studies
were preclinical animal studies with good methodological quality. Five studies compared DBM augmentation with non-DBM
controls, of which 4 (80%) reported positive findings in terms of histological and biomechanical outcomes.
Conclusion: Preclinical evidence indicates that DBM can improve tendon-bone healing, although clinical studies are lacking. A
range of animal models of tendon repair and ACLR showed that DBM can re-create a direct fibrocartilaginous enthesis, although
the animal models are not without limitations. Before clinical trials are justified, research is required that determines the best
source of DBM (allogenic vs xenogenic) and the best form of DBM (demineralized cortical bone vs DBM paste) to be used in
them.
Keywords: ACL; biologic healing enhancement; demineralized bone matrix; demineralized cortical bone; rotator cuff; tendon-
bone healing
Tendon and ligament insert into bone at a specialized site
called the enthesis, which allows efficient stress distribu-
tion from muscle to bone during joint motion.2 “Direct”
entheses occur at anatomic sites that are subject to high
loading and cyclic stress and exhibit a 4-zone gradient in
tissue, with varying tissue composition having different
mechanical properties.5 The first zone is tendon, similar
to that found in the tendon midsubstance, with a composi-
tion of well-aligned collagen I fibers; the second zone is
fibrocartilage, with a composition of type II and III colla-
gen; the third zone is calcified fibrocartilage, with a com-
position predominately of type II collagen; and the fourth
*Address correspondence to Adam T. Hexter, MBBS(Hons), BSc,
MRCS, Institute of Orthopaedic and Musculoskeletal Sciences, University
College London, Royal National Orthopaedic Hospital, Brockley Hill,
Stanmore, Middlesex, HA7 4, UK (email: a.hexter@ucl.ac.uk).
†Institute of Orthopaedic and Musculoskeletal Sciences, University
College London, Royal National Orthopaedic Hospital, Middlesex, UK.
‡University College Hospital, London, UK.
The authors declared that they have no conflicts of interest in the
authorship and publication of this contribution.
The Orthopaedic Journal of Sports Medicine, 5(10), 2325967117734517
DOI: 10.1177/2325967117734517
ª The Author(s) 2017
1
This open-access article is published and distributed under the Creative Commons Attribution - NonCommercial - No Derivatives License (http://creativecommons.org/
licenses/by-nc-nd/4.0/), which permits the noncommercial use, distribution, and reproduction of the article in any medium, provided the original author and source are
credited. You may not alter, transform, or build upon this article without the permission of the Author(s). For reprints and permission queries, please visit SAGE’s website at
http://www.sagepub.com/journalsPermissions.nav.
zone is bone, characterized by type I collagen and mineral
content.47 The tidemark refers to the mechanical boundary
between the calcified and uncalcified fibrocartilaginous
zones, and it is important for reducing damage to soft
tissues during joint movement.1 The anterior cruciate liga-
ment (ACL) and rotator cuff insertion are examples of direct
entheses that develop via endochondral ossification.46
“Indirect” entheses are typically found atmetaphyseal inser-
tions and are characterized by dense fibrous tissue that
attaches to bone indirectly through the periosteum.4
Direct entheses are susceptible to overuse injuries and
trauma.4 Following injury, the body is unable to regener-
ate a direct-type fibrocartilaginous enthesis but instead
forms an indirect-type enthesis with inferior biomechani-
cal properties that can lead potentially damaging stress
concentrations.8,17,42 In the context of rotator cuff injuries
following tendon repair, studies have shown that the
defect is replaced by biomechanically inferior fibrovascu-
lar tissue,8,17,26,41,44 and high rates of rerupture have been
reported.16 When associated with osteopenia of the
greater tuberosity, this appears to be associated with com-
promised suture anchorage for operative repair and
reduced pullout strength.7,50 Similarly, following ACL
reconstruction (ACLR), the graft heals by fibrovascular
scar tissue at the graft-tunnel interface,24,39 which might
contribute rerupture rates of up to 6% at 10-year follow-
up.11 Augmentation of healing at damaged insertion sites
remains a surgical challenge for orthopaedic surgeons,
and research investigating biological methods to enhance
tendon-bone healing is ongoing.15,28
Demineralized bone matrix (DBM) is an osteoinductive
agent that consists of a collagen scaffold containing sev-
eral growth factors, such as bone morphogenetic proteins
(BMPs), insulin growth factor, transforming growth fac-
tor, and fibroblast growth factor.48 The manufacture of
DBM was first described by Urist,48 and it involves acid
extraction of mineral component from bone tissue.13
Urist described how the implantation of DBM into a soft
tissue site led to the formation of bone through endo-
chondral ossification, and this article led to the discovery
of BMPs. Allogenic DBM poses minimal risk of foreign-
body immunogenic reaction and is in current use clini-
cally for treating bone defects in cases of nonunion.56
The promise behind DBM for tendon-bone healing in
tendon and ligament injuries is that it can induce new
bone formation via endochondral ossification38 and produce
a direct-type fibrocartilaginous insertion similar to the
native enthesis.43 In the context of rotator cuff and ACL
injuries, the hope is that DBM will promote differentiation
of the newly formed tendon-bone junction into a direct-type
insertion instead of fibrovascular tissue, which could pro-
vide physiological distribution of tensile forces onto the
bone insertion site and improve surgical outcomes.
The purpose of this systematic review was to (1) critique
preclinical and clinical evidence regarding the use of DBM
to biologically augment tendon-bone healing; (2) provide a
descriptive summary of the current evidence for DBM use
in tendon repair and ACLR, as this is the first systematic
review on the topic; and (3) highlight areas of future
research to facilitate clinical translation.
METHODS
This systematic review was conducted in accordance with
PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) guidelines. This review
included original peer-reviewed studies based on the fol-
lowing criteria: (1) publication in an English-language
journal and (2) an in vivo animal study or clinical study
that evaluated the use of DBM in the treatment of tendon
repair or ACLR. Studies evaluating biological interventions
with recombinant pharmaceutical agents (eg, BMPs in
bone defects, spinal injuries, and meniscal injuries) were
excluded because the purpose of this review was to focus
on DBM applications for tendon-bone healing. Studies
reporting in vitro work without in vivo analysis were
excluded.Only original peer-reviewedarticleswere included,
so letters, editorials, and review articles were excluded.
The search engines used to identify studies were MED-
LINE and EMBASE. The following search terms were used
for the literature search: (“demineralized/demineralised
bone matrix” OR “demineralized/demineralised cortical
bone”) AND (“tissue scaffold” OR “tissue engineering” OR
“ligament” OR “tendon” OR “anterior cruciate ligament”
OR “rotator cuff”). Searches were performed on February
10, 2017, with no date limit applied.
Studies were first screened to assess suitability for inclu-
sion according to the criteria. Then, full article review was
performed by 2 authors (A.T.H. and G.B.) to extract the fol-
lowing information: details of the animal model, the groups
investigated, the methods of evaluation, and the main find-
ings. Assessment of the study methodological quality was
undertaken by 2 authors (A.T.H. and G.B.) using criteria
modified from those proposed byHooijmans et al,18 as shown
in Table 1. The clinical relevance of outcome measures used
in animal studies was scored with a peer-reviewed system15
as follows: A, clinically useful quantitative outcome mea-
sures (eg, anterior-posterior knee laxity); B, biomechanical
testing (eg, ultimate tensile strength of the graft); C, quan-
titative biochemical outcomes (eg, immunohistochemistry);
D, semiquantitative histological analysis; and E, simple non-
quantitative histological analysis. Interrater reliability was
calculated with intraclass correlation coefficient mean mea-
sures (SPSS Statistics, v 22; IBM).
RESULTS
Search Results
Figure 1 outlines the process for evaluating studies for inclu-
sion in the systematic review. A total of 339 articles were
identified through our search literature search. After
removal of duplicates and screening to exclude irrelevant
studies, 16 studies underwent full review. Of these, 3 were
excluded because they were not written in English, 2
because they were conference papers, and 3 because they
were related to tissue engineering of cartilage defects.31,34,53
Eight articles met inclusion criteria: the characteristics of
the 4 studies14,43-45 that evaluated tendon injuries are shown
in Table 2, and the characteristics of the 4 studies19,20,22,27
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that evaluated ACLR are shown in Table 3. No clinical stud-
ies were identified, and all 8 studies were preclinical animal
studies. The median length of follow-up was 12 weeks (used
in 4 studies) and ranged from 6 weeks to 1 year. Six stud-
ies19,22,27,43,44,45 evaluated DBM in paste form, and 2 stud-
ies14,20 evaluated DBM in the form of demineralized cortical
bone (DCB). Five studies14,20,22,43,44 evaluated allogenic
DBM, and 2 studies19,27 evaluated xenogenic DBM, with 1
study45 comparing the 2 forms directly. One study45 evalu-
ated a combination of biological interventions, which com-
bined mesenchymal stem cells with DBM.
Assessment of Methodological Quality
The scores for methodological quality (out of 8) for all stud-
ies were as follows: 5 for 2 studies, 6 for 2 studies, 7 for 2
studies, and 8 for 2 studies. Acceptable interrater reliability
was seen between the 2 reviewers (intraclass correlation
coefficient mean measures, 0.792). Consensus on final
scores was reached following mutual discussion, with the
majority of differences between reviewers seen in their
evaluation of the robustness of the statistical analysis used
in the studies. Studies lost points for not performing biome-
chanical testing (n ¼ 5), conducting bilateral operations in
1 animal (n ¼ 2), and not having an appropriate control
group/statistics (n ¼ 4).
In terms of outcome measures, 4 studies ranked A, 1
study ranked B, 1 study ranked C, and 2 studies ranked
D. All studies used histological outcomes, with quantitative
histological analysis performed in 6 studies.19,22,27,43,44,45
Immunohistochemistry was utilized in 2 studies,19,27 with
both measuring BMPs and vascular endothelial growth fac-
tor. Biomechanical testing was performed in 3 stud-
ies,20,27,43 consisting of various tensile failure tests.
Peripheral quantitative computed tomography was used
in 4 studies14,27,44,45 to assess bone formation at the graft-
tunnel interface. Four studies14,20,43,45 evaluated quantita-
tive outcome measures analogous to clinical outcome
measures, such as gait analysis and knee laxity.
Appraisal of Study Outcomes
In this systematic review, we defined a positive finding as a
study where the use of DBM augmentation provided supe-
rior results in terms of histological scores as compared with
a nonaugmented control group. Out of the 8 studies,
519,22,27,43,44 compared DBM with a nonaugmented control
group. Of these 5, 419,22,27,43 demonstrated positive results
for DBM augmentation, and 144 observed no difference. Of
the 3 studies with no nonaugmented control, 145 compared
2 types of DBM (allogenic and xenogenic) and showed that
allogenic DBM was superior in terms of histological and
gait analysis. The other 2 studies14,20 reported favorable
findings of DBM-augmented constructs in terms of histo-
logical, biomechanical, and radiological outcomes but did
not compare their findings with a control group.
DISCUSSION
DBM is an osteoinductive scaffold that has potential in
augmentation of tendon-bone healing. This systematic
review found that the level of evidence pertaining to the
use of DBM in tendon-bone healing is low and remains at
the preclinical stage. In this section, we appraise the exist-
ing 8 animal studies, critique the representativeness of ani-
mal models, and highlight areas for future research if
clinical translation is to be achieved.
DBM in Tendon Repair
Four studies evaluating DBM in tendon repair were
reported, all of which were from the same laboratory, con-
sisting of 3 studies with a sheep animal model and 1 with a
rodent animal model. The first study to evaluate the use of
DBM at a healing enthesis was based on an ovine patellar
tendon model,43 which allows functional recovery to be
directly evaluated because the entire extensor mechanism
TABLE 1
Scoring Criteria for Methodological Quality of
Animal Studies of Tendon-Bone Healinga
Criteria Scores Comments
Unit of sample Unilateral, 1;
bilateral, 0
Studies with bilateral
operation may regard
limbs as independent
samples and assign
them to different
treatment groups
Standardization
of surgical
procedure
Yes, 1; no, 0 Descriptions about graft
harvest, surgical
approach, drilling
tunnels, graft
tensioning, and fixation
method are important
Description of
surgical
complications
Yes, 1; no, 0 Details such as wound
infection and
postoperative morbidity
and mortality
Biomechanical
testing
Yes, 1; no, 0 Mechanical testing is a
useful outcome when
assessing tendon-bone
healing
Variation (ratio of
SD to mean)
<50%, 1; >50%, 0 Large SD may imply poor
precision or large
intragroup variations
Statistical
method and
control group
Appropriate, 1;
inappropriate, 0
Appropriate statistical
tests were used, such as
analysis of variance or
Kruskal-Wallis test
Description of
tendon-bone
interface
Yes, 1; no, 0 During histological
analysis, sampling
description for region of
interest is important
Semiquantitative
histological
analysis
Yes, 1; no, 0 During histological
analysis, the use of
scoring systems
indicates better study
quality
aModified from Hooijmans et al.18
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depends on the tendon-bone interface. Ovine patellar ten-
don was detached from its insertion on the tibia and
repaired with suture anchors alone (control group) or with
allogenic DBM interposed between the tendon and bone
(intervention group). After 12 weeks, the DBM group
demonstrated better functional weightbearing than
the controls and with no failures, compared with 33% fail-
ure in the control group. Histologically, the control group
demonstrated a largely fibrous insertion, whereas in the
DBM group, the tendon-bone interface had remodeled
into an organized fibrocartilaginous insertion with
mineralization.
Elnikety et al14 reported that DBM successfully repaired
“large tendon” defects in their work, where allogenic DBM in
the form of a strip (ie, DCB) was used to replace a large
patellar tendon defect in 6 sheep. After 12 weeks, there was
evidence of mature remodeling with the formation of a
neoenthesis composed of fibrocartilage and mineralized
fibrocartilage. Polarized microscopy confirmed that the
haversian system arrangement of the bone was lost and that
the collagen had remodeled into a longitudinal arrangement,
indicating the process of “ligamentization.”35
The only study identified in this systematic reviewwith a
negative finding used a chronic rotator cuff tear model in
rats.44 In this study, when compared with nonaugmented
repair and augmented repair with commercially available
dermal matrix, allogenic DBM was not associated with
improved histological remodeling. In all animals, histo-
logical analysis showed that the tendon-bone gap
closed with a fibrocartilaginous insertion, although the
degeneration of the tendon was not reversed. Bone mineral
density was measured with peripheral quantitative com-
puted tomography at the humeral head, as this is thought
to influence pullout strengths,7 and nonaugmented repairs
had higher bone mineral density than both augmented
groups.
Thangarajah et al45 reported the first and only study to
date that utilized a combination of stem cells with DCM to
evaluate tendon-bone healing. In this work, a 1-cm trans-
verse patellar tendon defect in an ovine model was
repaired with suture anchors and either allogenic or xeno-
genic DBM combined with minimally manipulated mesen-
chymal stem cells isolated by centrifugation of iliac crest
bone marrow aspiration during surgery. After 12 weeks, a
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Figure 1. A flowchart showing the selection of studies for inclusion in the systematic review. ACLR, anterior cruciate ligament
reconstruction.
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4-zone direct neoenthesis was observed in both groups, but
the allograft DBM group was associated with more mature
fibrocartilaginous and higher functional weightbearing
scores. The authors attributed the better outcome seen
in the allograft group to the fact that ovine bone has a
higher density of bone when compared with porcine bone,
TABLE 2
Animal Studies Investigating DBM in Tendon Repaira
Publication Animal Model DBM Form Follow-up Groups (No.) Methods (wk) Findings
Positive
Findingb
Quality
Scorec
Evidence
Level
Thangarajah
et al44
(2017)
Rat model
of chronic
rotator cuff
tear
DBM (allogenic) 6 wk DBM (6), dermal
scaffold (6),
control (no
augmentation)
(6)
SQ histological
analysis (6),
pQCT (6)
The application of DBM
did not improve the
composition of the
healing enthesis when
compared with
nonaugmented controls
and a commercially
available scaffold.
Nonaugmented repairs
exhibited a significantly
higher bone mineral
density than DBM
No 7 D
Elnikety
et al14
(2016)
Ovine patellar
tendon model
(large defect)
DCB (allogenic) 12 wk DCB (6), no
control group
Gait analysis
(3, 9, 12),
radiographs
(12), ROM (12),
pQCT (12),
histological
analysis (12)
Functional weightbearing
significantly increased
from 44% at week 3 to
79% at week 12. The
formation of a
neoenthesis with the
presence of
fibrocartilage and
mineralized
fibrocartilage was seen
in all specimens.
Collagen remodeling
with “ligamentization”
of the DCB was
observed
n/a 6 A
Thangarajah
et al45
(2016)
Ovine patellar
tendon model
DBM (allogenic,
xenogenic)
12 wk Allograft DBM
and mmMSCs
(5), xenogenic
DBM and
mmMSCs (5)
Gait analysis
(6, 9, 12),
pQCT (12), SQ
histological
analysis (12)
The allograft was
associated with
significantly higher
functional
weightbearing
throughout. The
allogenic group showed
greater remodeling of
the DBM into tendon-
like tissue in the region
of the defect, with the
presence of direct
enthesis associated with
more fibrocartilage
n/a 5 A
Sundar
et al43
(2009)
Ovine patellar
tendon model
DBM (allogenic) 12 wk DBM (8),
control (11)
Gait analysis,
(3, 6, 9, 12),
radiographs,
(3, 6, 9, 12),
mechanical/
UTS (0, 12),
SQ histological
analysis (6, 12)
Tendon repairs failed at a
rate of 33% and 0% for
the control and DBM
groups, respectively.
DBM augmentation
resulted in significantly
improved functional
weightbearing and
increased amounts of
fibrocartilage and
mineralized
fibrocartilage on
histology
Yes 8 A
aDBM, demineralized bone matrix; DCB, demineralized cortical bone; DCM, demineralized cortical bone; mmMSCs, minimally manipu-
lated mesenchymal stem cells; n/a, not applicable; pQCT, peripheral quantitative computer topography; ROM, range of motion; SQ, semi-
quantitative; UTS, ultimate tensile strength.
bWe define a positive finding as a study where DBM augmentation provided superior histological scores when compared with a non-
augmented control group.
cOut of 8.
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thus allowing better tolerance of the mechanical forces
and microtrauma across the graft. A limitation of this
study is that it did not have a group without minimally
manipulated mesenchymal stem cells, which makes the
influence of the stem cells on the outcome difficult to
determine.
TABLE 3
Animal Studies Investigating DBM in ACLRa
Publication
Animal
Model DBM Form Follow-up Groups (No.) Methods (wk/mo) Findings
Positive
Finding b
Quality
Scorec
Evidence
Level
Hsu and Wang
et al19 (2014)
Rabbit DBM
(xenogenic)
12 wk ACLR with DBM
in the tibial
tunnel (5),
ACLR alone (5)
Radiographs (4, 8, 12 wk),
histological analysis
(12 wk),
immunohistochemistry
(12 wk; VEGF and
BMP-2)
DBM group showed
less displacement of
tendon in tibial
tunnel and showed
better integration
between tendon and
bone. The DBM
group showed
significantly higher
expressions of VEGF
and BMP-2
Yes 5 C
Lovric
et al27(2012)
Rat DBM
(xenogenic)
6 wk ACLR with DBM
on graft/bone
tunnel (28),
ACLR alone
(28)
SQ histological analysis
(2, 4, 6 wk),
immunohistochemistry
(2, 4, 6 wk; BMP-2,
BMP-7, Smad4, VEGF,
CTSK), mechanical/
UTS (4, 6 wk), pQCT
(4, 6 wk)
The DBM group
showed increased
woven bone
formation and
enhanced bone
remodeling. The
DBM group had a
larger peak load to
failure of the tendon-
bone interface
Yes 8 B
Kilicoglu et al22
(2012)
Rabbit DBM
(allogenic)
9 wk ACLR alone (6),
ACLR with
DBM in bone
tunnel (6)
SQ histological analysis
(3, 6, 9 wk)
The DBM group
showed a higher
number of Sharpey-
like fibers, increased
fibrocartilage
formation, and new
bone formation
scores than the
control group in the
third week.
However, all
histological scores
were similar in both
groups in the sixth
and ninth weeks
Yes
(early)
6 D
Jackson et al20
(1996)
Goat DCB
(allogenic)
1 y ACLR with
DBM (14),
the contralateral
limb acted as
control
MRI (6, 12 mo),
histological analysis (6,
12 mo), examination for
AP laxity (12 mo),
mechanical/UTS (0,
12 mo)
AP testing was stable
at 1-y follow-up with
no failures. Bone
replaced the DBM in
the bone tunnels,
and a fibrocartilage
transition was seen
with no long-term
inflammatory
response. The time-
zero structural
properties of a
collagen matrix
increased to more
desired values after
12 mo, although was
less than controls
n/a 7 A
aACLR, anterior cruciate ligament reconstruction; AP, anteroposterior; BMP2, bone morphogenetic protein 2; BMP7, bone morphogenetic
protein 7; CTSK, cathepsin; DBM, demineralized bone matrix; DCB, demineralized cortical bone; DCM, demineralized cortical bone; MRI,
magnetic resonance imaging; n/a, not applicable; pQCT, peripheral quantitative computer topography; SQ, semiquantitative; UTS, ultimate
tensile strength; VEGF, vascular endothelial growth factor.
bWe define a positive finding as a study where DBM augmentation provided superior histological scores when compared with a non-
augmented control group.
cOut of 8.
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DBM in ACL Reconstruction
The longest in vivo follow-up of the use of DBM in ACL-bone
healing was in 1996when Jackson et al20 used allogenic DBM
in DCB form in a goat animal model of ACLR. DCB strips
were trimmed to fit through a femoral and tibial tunnel to
reconstruct the ACL. Histological analysis showed replace-
ment of DCB with bone within the osseous tunnels and the
presence of a more physiological fibrocartilage transition at
the graft insertion site. Magnetic resonance image scans
showed that the osseous tunnels were nearly obliterated with
a signal similar to bone. There was a 550% increase in graft
strength at 1 year, although the ultimate tensile strengthwas
statistically significantly less than control ACLs.
Kilicoglu et al22 evaluated the effect of allogenic DBM
within a tibial osseous tunnel in a rabbit model of ACL
injury and in the first 6 weeks observed slightly increased
fibrocartilage formation and more bone formation in the
DBM group than the nonaugmented control. However, the
superiority was short-term, and by 9 weeks, there were no
differences in histology, with both groups showing replace-
ment of fibrocartilage with calcified cartilage and new bone.
Conversely, Hsu and Wang19 found that rabbits that had
xenogenic (human) DBM applied to the tibial tunnel
showed superiority versus nonaugmented repair at 12
weeks. Histological examination showed more intimate
contact between tendon and bone in the DBM group with
more mineralized fibrocartilage between tendon and bone,
which corresponded to higher levels of expression of BMP-2
and vascular endothelial growth factor.
Lovric et al27 performed a study with a rodentmodel where
the intervention group had xenogenic (human) DBM inserted
into the femoral and tibial bone tunnels before reconstruction.
When compared with a control group, the DBM group had
considerably more woven bone formation at the interface, as
confirmed on histology and micro–computed tomography,
which was associated with statistically higher levels of peak
load to failure of the tendon-bone interface. Immunohisto-
chemistry revealed higher levels of BMPs throughout, such
as BMP-2 and BMP-7, which were thought to be responsible
for the higher level of new bone formation.
Representativeness of Animal Models
Animal models are a useful way to investigate interven-
tions and to see if it is worthwhile to take them into human
clinical trials.9 Requirements of animal models in transla-
tional orthopaedic research into tendon-bone healing
include the following: the model must be comparable to the
human environment; the surgery must be feasible, afford-
able, and ethically acceptable; and animals need to be able
to tolerate the rehabilitation and have suitable facilities
available.30 A range of small-animal models (rodents,
rabbits)19,22,27,44 and large-animal models (goats,
sheep)20,43,45 has been used to evaluate the effect of DBM
on tendon-bone healing; nevertheless, they are not without
limitations. Considerable anatomic differences exist
between animals and humans, especially in terms of gait
and posture, which can lead to different biomechanical
stresses.37 The use of rodent animal models makes the
interpretation of results for humans difficult. Rodent mod-
els seem to produce significant amounts of fibrous tissue
that are not seen in humans, and the pathology associated
with tendon damage is different from humans.6 The limited
surface area in rodent models might not create an environ-
ment conducive to healing owing to high shear forces, which
brings into question the suitability of rodent models for
assessing tendon-bone healing44 and might account for the
rodent animal model being unable to reproduce promising
results seen with DBM in the large-animal models. Further
doubt over the suitability of rodent models of rotator cuff
pathology is that spontaneous bone healing of the humerus
occurs, which is not thought to happen in humans.44
There have been 3 large-animal studies (ovine) investi-
gating tendon injury, but the use of DBM for ACLR has
been investigated in only 1 large-animal model (goat).
There have been 3 large-animal studies (ovine) investigat-
ing tendon injury, but the use of DBM for ACLR has been
investigated in only 1 large-animal model (goat). A limita-
tion of the studies using large-animal models is that they
have used a relatively low number of animals with no
reported power calculation. Reasons why studies using
small animals generally evaluate larger numbers of ani-
mals include small animals (eg, rabbits) having simpler
requirements for animal maintenance and housing when
compared with larger animals, as well as their potential for
faster postoperative recovery.3 Dogs33,40 and pigs10,23 are
recognized large-animal models of ACLR that have not
been used to evaluate DBM modulation of ACLR, despite
some evidence that pigs best reflect human knee in situ
forces.55 In the context of tendon injuries, large-animal
models have only simulated acute injuries, with the only
chronic model of disease being a study in rodents. Acute
injury models are useful when investigating the formation
of the enthesis, but they do not consider the condition of the
tendon, which, in human clinical situations at the time of
surgery, is retracted with fatty infiltration.9,17 Similarly, in
models of ACLR, the creation of the injury and the surgical
reconstruction have always occurred in the same operation,
which does not reflect the delay seen in human patients
between injury and surgery owing to the preoperative
workup. This might have implications because during
acute injury there is a release of cytokines and a change
in gene expression, whichmight create a biological environ-
ment different from that seen in human patients undergo-
ing ACLR.49,54
The published animals models reported here are also
relatively short term, and in this analysis, most of the stud-
ies were conducted for <6 months. While this length of time
may be appropriate for investigating bone-graft integra-
tion, remodeling and ligamentization may take longer. In
addition, the surgical procedures for the ACL animal mod-
els have all been open, which does not reflect the current
surgical practice of arthroscopic reconstruction.
Steps Toward Clinical Translation
This systematic review aimed to review preclinical and
clinical evidence behind the use of DBM to augment
tendon-bone healing. There were no clinical studies
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identified, which means that general statements about the
effectiveness of DBM to augment tendon-bone healing
cannot be made.
More preclinical data are required to justify the use of
DBM in clinical trials, and the following areas need to be
addressed in particular. First, the best source and method
of manufacturing DBM for clinical applications need to be
determined,12 reflected by the fact that the strength and
biological activity of DBM that is currently available are
variable. The biological activity of bone obtained from a
young donor compared with that from an older individual
would be different; therefore, there is not a consistent sup-
ply of DCB. Xenogeneic DCBmight be advantageous, as the
biological activity of the graft material would be reproduc-
ible and there would be an unlimited supply of graft mate-
rial, although there might be problems with immunogenic
activity. Thangarajah et al45 showed that allograft has
superior results to xenograft in tendon-bone healing, but
further studies comparing xenograft and allograft, with
long-term follow-up assessing for immunological reactions,
are needed before DBM can be used in humans.
Second, DBM can be created in the form of DCB,44
although this is not commercially available at present. The-
oretically, instead of being used to augment tendon recon-
struction, the DCB could be used as the primary graft
material for reconstruction, with the promise of forming a
tendon enthesis via endochondral ossification. Future
large-animal studies of ACLR are required that compare
DCB reconstruction with DBM augmentation, but these
need to have follow-up for at least 6 months to provide time
for ligamentization to occur.35 In addition, longer-term
studies are needed to clarify if the benefit of DBM is just
in the first 3 weeks, as suggested by 1 study,22 or longer
lasting, as suggested by others.19,43,45
Finally, as tendon healing involves different stages, such
as inflammation, vascularization, and remodeling, it might
be possible to enhance tendon-bone healing by using a com-
bination of biological interventions. Future animal studies
that combine DBM with other biological approaches to
augment tendon-bone healing merit investigation, such as
tissue scaffolds,25,36,57 gene therapy,21,29,32 and biophysical
interventions.51,52 Before biological interventions achieve
clinical translation in addition to demonstrating safety pro-
file and clinical efficacy, they will need to be cost-effective
given the current environment of cost containment.
CONCLUSION
The enthesis has a complex composition, structure, and
mechanical behavior that effectively transfer stress from
tendon to bone. Injuries to the rotator cuff and ACL are
common sports injuries that have high rates of early fail-
ure, which is thought to be due in part to inadequate heal-
ing at the tendon-bone interface. DBM is a promising
biomaterial because it provides a protein scaffold with its
own supply of growth factors capable of repairing small/
large tendon defects and it augments ACLR by creating a
4-zone fibrocartilaginous enthesis and enhancing osseoin-
tegration. DBM shows promise in animal studies, but the
use of DBM in tendon-bone healing remains in the explor-
atory stage with no clinical research undertaken. Future
research is required to determine the best source (allogenic
versus xenogenic) and best form (augmentation versus
reconstruction) of DBM to take forward into clinical trials.
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